Warning letter
Kamiya Biomedical Company: warning letter of Nov 14, 2001
FDA warning letter UCM178827 · Seattle District Office
Key facts
| Reference number | UCM178827 |
|---|---|
| Company | Kamiya Biomedical Company |
| Subject | Quality System Regulation for Medical Devices/Adulterated |
| Issue date | Nov 14, 2001 |
| Posted date | Nov 14, 2001 |
| Issuing office | Seattle District Office |
| Product type | Devices |
| CFR sections cited | 820 |
| Country | 3 |
| Inspection city | Tukwila |
| Inspection ZIP | 98168-3308 |
| Inspection start date | Sep 12, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: